A. Bosly

Y. De Gheldre, Y. Glupczynski, Y. Gheldre, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prognosis of hematologic malignancies does not predict intensive care unit mortality

J. Jamart, C. Doyen, P. Bulpa, 2002, Critical care medicine.

Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

P. Gaulard, F. Berger, B. Coiffier, 1998, Blood.

des Lymphomes de l'Adulte (GELA) trials angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude Clinical, biologic, and pathologic features in 157 patients with

P. Gaulard, B. Coiffier, J. Diebold, 2013 .

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

P. Gaulard, B. Coiffier, J. Diebold, 2008, Blood.

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

P. Gaulard, B. Coiffier, H. Tilly, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study

P. Gaulard, B. Coiffier, H. Tilly, 1996 .

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

T. Molina, B. Coiffier, H. Tilly, 2003, Blood.

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients.

M. Lübbert, M. André, G. Verhoef, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remission.

A. Delannoy, P. Martiat, D. Latinne, 1991, Bone marrow transplantation.

Routine use of platelet components prepared with photochemical treatment (INTERCEPT platelets): Impact on clinical outcomes and costs.

L. Corash, C. Doyen, A. Sonet, 2004 .

GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors.

B. Nadel, C. Copie-Bergman, T. Molina, 2019, Cell metabolism.

Vindesine and Prednisone in the Treatment of Relapsed Lymphomalignancies, Blastic Crisis of Chronic Myelocytic Leukemia and Acute Myelomonocytic Leukemia

A. Delannoy, A. Ferrant, G. Sokal, 1981 .

A phase II study of vindesine in patients with hematological malignancies.

A. Delannoy, A. Ferrant, J. Michaux, 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Late Intensification Chemotherapy and Autologous Bone-marrow Transplantation in Small Cell Lung-cancer

Y. Humblet, L. Delaunois, M. Symann, 1982 .

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

P. Gaulard, F. Berger, B. Coiffier, 2003, Blood.

Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers.

M. Negrini, P. Cin, L. Van Hove, 1992, Blood.

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

R. Greil, P. Gaulard, G. Salles, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

P. Gaulard, G. Salles, B. Coiffier, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequentisl induction chemotherapy with vincristine, daunorubicin cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia

C. Sebban, X. Thomas, E. Archimbaud, 1995, Annals of Hematology.

Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia.

X. Thomas, P. Dufour, B. Corront, 1995, Annals of hematology.

High efficacy of recombinant urate oxidase in prevention of renal failure related to tumor lysis syndrome (TLS).

G. Leverger, C. Patte, J. Boos, 1998 .

Risk assessment and medical decision model for prophylaxis and treatment of hyperuricemia and tumor lysis syndrome (TLS): International expert panel analysis

C. Pui, B. Coiffier, B. Cheson, 2007 .

B. Coiffier, C. Gisselbrecht, N. Mounier, 2006 .

Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).

C Sebban, B. Coiffier, H. Tilly, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients.

C. Mecucci, P. Martiat, A. Cuneo, 1989, Blood.

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

W. Klapper, E. Hoster, G. Salles, 2016, The Lancet.

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study

C. Copie-Bergman, T. Molina, F. Jardin, 2016, Clinical Cancer Research.

Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.

H. Dombret, M. Dennis, P. Fenaux, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Translocation t(8;16)(p11;p13) in acute non-lymphocytic leukemia: report on two new cases and review of the literature.

C. Mecucci, M. Stul, L. Michaux, 1996, Leukemia & lymphoma.

A phase I study of vinblastine tryptophan ester

Y. Humblet, M. Symann, A. Bosly, 2004, Cancer Chemotherapy and Pharmacology.

Rituximab and chemotherapy in diffuse large B-cell lymphoma

A. Sonet, A. Bosly, 2009, Expert review of anticancer therapy.

Place de l'association de l'anticorps monoclonal anti-CD20 avec les agents immunomodulateurs.

A. Bosly, 2004 .

Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC)

Y. Humblet, M. Beauduin, M. Symann, 1990, Medical oncology and tumor pharmacotherapy.

A Phase II study of SGN‐30 (anti‐CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma

J. Leonard, A. Younes, N. Bartlett, 2009, British journal of haematology.

standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma Intensive conventional chemotherapy (ACVBP regimen) compared with

T. Molina, B. Coiffier, H. Tilly, 2009 .

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.

T. Molina, B. Coiffier, H. Tilly, 2005, The New England journal of medicine.

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.

P. Gaulard, G. Salles, B. Coiffier, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, P. Biron, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1997, Leukemia & lymphoma.

Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.

J. Machiels, Y. Humblet, M. Beauduin, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome.

C. Mecucci, H. van den Berghe, M. Boogaerts, 1989, Cancer genetics and cytogenetics.

Acute leukaemia in paroxysmal nocturnal haemoglobinuria. Case report and review of the literature.

C. Doyen, F. Cornélis, B. Châtelain, 1996, Hematology and cell therapy.

Trisomy 3 is a consistent chromosome change in malignant lymphoproliferative disorders preceded by cold agglutinin disease

A. Delannoy, C. Mecucci, M. Stul, 1995, British journal of haematology.

Possible toxicity with the association of G-CSF and bleomycin

B. Coiffier, C. Gisselbrecht, F. Reyes, 1994, The Lancet.

Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?

P. Martiat, A. Ferrant, D. Bron, 1999, Bone Marrow Transplantation.

Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte.

G. Salles, B. Coiffier, H. Tilly, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.

Catherine Thieblemont, Nicolas Mounier, Richard Delarue, 2013, The Lancet. Oncology.

Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, C. Gisselbrecht, N. Brousse, 1993, The New England journal of medicine.

(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.

B. Coiffier, H. Tilly, C. Gisselbrecht, 2011, Clinical lymphoma, myeloma & leukemia.

Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low–intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol

T. Molina, B. Coiffier, H. Tilly, 2010, Leukemia & lymphoma.

Cytogenetic responses in high‐risk myelodysplastic syndrome following low‐dose treatment with the DNA methylation inhibitor 5‐aza‐2′‐deoxycytidine

M. Lübbert, M. André, G. Verhoef, 2001, British Journal of Haematology.

Inversions of chromosome 12 in human malignancies.

C. Mecucci, H. van den Berghe, C. Doyen, 1987, Cancer genetics and cytogenetics.

Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial

T. Molina, O. Casasnovas, P. Feugier, 2022, Blood advances.

Addition of High-Dose Cytarabine to Immunochemotherapy before Autologous Stem-Cell Transplantation in Patients Aged 65 Years or Younger with Mantle Cell Lymphoma (MCL Younger): A Long-Term Follow-up of the Randomized, Open-Label, Phase 3 Trial of the European Mantle Cell Lymphoma Network

W. Klapper, E. Hoster, G. Salles, 2021, Blood.

Plasmapheresis: an effective therapy for cholestatic episodes related to benign recurrent intrahepatic cholestasis?

A. Delannoy, A. Geubel, A. Bosly, 1988, Annales de medecine interne.

90Yttrium ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory. follicular lymphoma. GELA phase II study

B. Coiffier, H. Tilly, C. Gisselbrecht, 2007 .

2-Chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinaemia.

A. Delannoy, P. Martiat, A. Ferrant, 1994, Nouvelle revue francaise d'hematologie.

Cladribine for Waldenström's macroglobulinaemia

A. Delannoy, A. Ferrant, J. Michaux, 1999, British journal of haematology.

Late intensification chemotherapy with autologous bone marrow infusion in small cell lung cancer: preliminary results of a randomized trial

J. Machiels, Y. Humblet, L. Delaunois, 1984 .

High‐dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study

A. Delannoy, P. Martiat, C. Doyen, 1990, European journal of haematology.

A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B‐cell lymphoma

B. Coiffier, J. Radford, G. Martinelli, 2013, British journal of haematology.

Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndrome.

A. Delannoy, P. Martiat, A. Ferrant, 1996, Leukemia & lymphoma.

Acute lymphoblastic leukemia in the elderly

A. Delannoy, P. Martiat, C. Doyen, 1990, European journal of haematology.

Ofatumumab Monotherapy for Treatment of Patients with Relapsed/Progressive Diffuse Large B-Cell Lymphoma: Results From a Multicenter Phase II Study

B. Coiffier, J. Radford, G. Martinelli, 2010 .

High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network

W. Klapper, E. Hoster, W. Hiddemann, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma

W. Klapper, E. Hoster, L. Sehn, 2022, Blood advances.

Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

B. Coiffier, R. Bouabdallah, O. Casasnovas, 2013, European journal of cancer.

Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.

P. Gaulard, C. Gisselbrecht, É. Lepage, 2001, The hematology journal : the official journal of the European Haematology Association.

BEACOPPescalated versus ABVD in advanced Hodgkin's lymphoma.

M. André, A. Bosly, 2013, The Lancet. Oncology.

From health locus of control to immune control: internal locus of control has a buffering effect on natural killer cell activity decrease in major depression

B. Châtelain, C. Reynaert, A. Bosly, 1995, Acta psychiatrica Scandinavica.

FDG PET Utility in Paraneoplastic Sweet Syndrome

T. Vander Borght, B. Krug, A. Sonet, 2004, Clinical nuclear medicine.

Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: A dose escalation study of carboplatin

D. Rodenstein, Y. Humblet, M. Beauduin, 1989, Medical oncology and tumor pharmacotherapy.

comments) adult acute myeloid leukemia expressing lymphoid markers (see Correlation of cytogenetic patterns and clinicobiological features in

M. Negrini, P. Cin, M. Stul, 2011 .

Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study

R. Paridaens, C. Jackisch, M. Schwenkglenks, 2008, Supportive Care in Cancer.

Evaluation of a low density DNA microarray for small B-cell non-Hodgkin lymphoma differential diagnosis

T. Molina, P. Gaulard, J. Hamels, 2009, Leukemia and Lymphoma.

Secondary neoplasms in two patients treated with purine analogues.

P. Brousset, A. Delannoy, A. Bosly, 1994, Nouvelle revue francaise d'hematologie.

Independent Predictive Value of PET-CT Pre Transplant in Relapsed and Refractory Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Included in the CORAL Study.

N. Schmitz, S. Montoto, C. Gisselbrecht, 2009 .

Intensive remission induction and consolidation therapy in patients with acute myeloid leukaemia.

A. Delannoy, C. Doyen, A. Ferrant, 1987, British journal of haematology.

Alternating Chemotherapy Does Not Improve Results in Poor-prognosis Aggressive Lymphomas - Lnh87 Protocol Group-3 - a Gela Study

P. Gaulard, B. Coiffier, H. Tilly, 1993 .

Final Results of a Randomized Phase 2 Multicenter Study of Two Bortezomib Schedules In Patients with Recurrent or Refractory Follicular Lymphoma. Groupe d'Etude Des Lymphomes De l'Adulte (GELA) Study FL-05

B. Coiffier, R. Bouabdallah, O. Casasnovas, 2010 .

A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.

J. Machiels, P. Martiat, C. Doyen, 1992, Acta clinica Belgica.

R-ICE Versus R-DHAP in Relapsed Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Followed by Stem Cell Transplantation and Maintenance Treatment with Rituximab or Not: First Interim Analysis on 200 Patients. CORAL Study.

N. Schmitz, P. Gaulard, C. Gisselbrecht, 2007 .

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

A. Ferrando, D. Gilliland, A. Look, 2004, Nature Genetics.

A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma.

A. López-Guillermo, B. Coiffier, H. Holte, 2013, The oncologist.

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

J. Armitage, S. Jagannath, P. Biron, 1987, The New England journal of medicine.

Cytogenetic remissions in high-risk myelodysplastic syndrome: Results in 124 patients treated with low-dose 5-aza-2 '-deoxycytidine (Decitabine), a DNA methylation inhibitor.

M. Lübbert, M. André, A. Ferrant, 2000 .

2‐chlorodeoxyadenosine and multiple myeloma

A. Delannoy, P. Martiat, A. Ferrant, 1994, European journal of haematology.

Cytogenetics of hybrid acute leukemias.

A. Cuneo, H. van den Berghe, M. Boogaerts, 1995, Leukemia & lymphoma.

SGN-30 (Anti-CD30 mAb) Has a Single-Agent Response Rate of 21% in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma (ALCL).

J. Leonard, B. Cheson, H. Holte, 2006 .

B. Coiffier, C. Haioun, J. Gabarre, 2013, European journal of cancer.

Clinical , biologic , and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d ’ Etude des Lymphomes de l ’ Adulte ( GELA ) trials

P. Gaulard, B. Coiffier, R. Bouabdallah, 2008 .

High-dose cytosine arabinoside intensification for acute nonlymphocytic leukemia in patients over 56 years of age

V. Deneys, P. Martiat, C. Doyen, 1992, Annals of Hematology.

Long term results of the GELA study, R-CHOP vs. CHOP in elderly patients with diffuse large B-cell lymphoma.

G. Salles, R. Bouabdallah, P. Feugier, 2004 .

Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study.

B. Coiffier, H. Tilly, C. Gisselbrecht, 2006 .